CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,029 | -16.0% | 4,161 | -38.8% | 0.00% | – |
| Q2 2023 | $73,829 | +31.3% | 6,794 | +8.7% | 0.00% | – |
| Q1 2023 | $56,250 | +44.2% | 6,250 | 0.0% | 0.00% | – |
| Q4 2022 | $39,000 | +77.3% | 6,250 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | +29.4% | 6,250 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -99.8% | 6,250 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $10,971,000 | +47600.0% | 6,250 | 0.0% | 0.02% | – |
| Q4 2021 | $23,000 | 0.0% | 6,250 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | +360.0% | 6,250 | +525.0% | 0.00% | – |
| Q1 2021 | $5,000 | -64.3% | 1,000 | -50.0% | 0.00% | – |
| Q3 2020 | $14,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |